by admin | Mar 19, 2019 | news
Innovative therapy reprograms immune cells and cures blood cancer New drug regulation, enforced on April, 1st, 2019, will further delay the access of Bulgarian patients to new medicines. This was announced by Deyan Denev, Executive Director of the Association of...
by admin | Mar 7, 2019 | news
GW Pharmaceuticals may be the first drugmaker to roll out a cannabis-based drug in the U.S., but it’s unlikely to be the last—and that’s why so many are keeping an eye on GW’s Epidiolex launch. So far, so good, executives and analysts said...
by Viara Staneva | Mar 7, 2019 | news
Not quite two years into his stewardship of the FDA, Scott Gottlieb, M.D., is stepping down. His sudden departure will likely send shock waves through biopharma, because the commissioner was popular for his market-based policies to lower...
